Aromatic amino acid decarboxylase deficiency: Clinical Trials

11 trials for Aromatic amino acid decarboxylase deficiency, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 3 recruiting, 2 active not recruiting, 1 unknown. 4 Phase 2, 2 Phase 1, 1 Early Phase 1, 1 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Active not recruiting 2, Completed 2
Phase 12Completed 1, Recruiting 1
Early Phase 11Recruiting 1
Not applicable1Unknown 1
Phase 31Active not recruiting 1

Follow Aromatic amino acid decarboxylase deficiency: new trials by email Literature Review of Aromatic amino acid decarboxylase deficiency trials Research Report on Aromatic amino acid decarboxylase deficiency

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Trial to Evaluate Safety and Efficacy of a Product Named VGN-R09b in Severe AADC Deficiency
VGN-R09b injection - Aromatic L-amino Acid Decarboxylase Deficiency
Phase 2 / Phase 3Active not recruitingShanghai Vitalgen BioPharma Co., Ltd.132024-07-022026-04-21
Newborn Screening and Early Diagnosis of AADC Deficiency in the Ligurian Population
Neurology, Aromatic Amino Acid Decarboxylase Deficiency
RecruitingIstituto Giannina Gaslini160002023-08-172026-10-16
An Early Clinical Trial to Evaluate VGN-R09b for Treatment of Aromatic L-amino Acid Decarboxylase (AADC) Deficiency.
VGN-R09b - Aromatic L-amino Acid Decarboxylase (AADC) Deficiency
Early Phase 1RecruitingShanghai Jiao Tong University School of Medicine62023-01-302023-03-13
Baby Detect : Genomic Newborn Screening
Congenital Adrenal Hyperplasia, Familial Hyperinsulinemic Hypoglycemia 1
CompletedCentre Hospitalier Universitaire de Liege68242022-09-012025-08-12
Prevalence of High Plasmatic 3OMethyldopa Level in a Specific Population of Patients With a Symptomatology Compatible With AADC Deficiency
Plasmatic 3-O-Methyldopa dosage - Aromatic L-Amino Acid Decarboxylase Deficiency
Not applicableUnknownUniversity Hospital, Montpellier3882022-05-202022-08-11
A Study of SmartFlow Magnetic Resonance (MR) Compatible Ventricular Cannula for Administering Eladocagene Exuparvovec to Pediatric Participants
Eladocagene Exuparvovec - AADC Deficiency
Phase 2Active not recruitingPTC Therapeutics132021-05-122026-04-24
Genetic Etiology in Patients With Cerebral Palsy
NGS - Cerebral Palsy, Genetic Disease
CompletedUniversity Medical Centre Ljubljana1502021-04-012022-11-02
A Clinical Trial for Treatment of Aromatic L-amino Acid Decarboxylase (AADC) Deficiency Using AAV2-hAADC - An Expansion
AAV2-hAADC - Aromatic Amino Acid Decarboxylase Deficiency
Phase 2CompletedNational Taiwan University Hospital122016-11-092023-02-10
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
AAV2-hAADC - AADC Deficiency
Phase 1RecruitingKrzysztof Bankiewicz422016-07-012026-08-27
A Phase I/II Clinical Trial for Treatment of Aromatic L-amino Acid Decarboxylase (AADC) Deficiency Using AAV2-hAADC
gene therapy - Aromatic L-amino Acid Decarboxylase (AADC) Deficiency
Phase 1 / Phase 2CompletedNational Taiwan University Hospital102014-10-222023-02-10
Newborn Screening for Aromatic L-amino Acid Decarboxylase Deficiency
Aromatic L-amino Acid Decarboxylase Deficiency
CompletedNational Taiwan University Hospital1547952012-08-012017-04-28

Narrower conditions

3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency (1)  ·  3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 Deficiency (1)  ·  Acidemia, isovaleric (1)  ·  Acyl-CoA Dehydrogenase Family, Member 9, Deficiency of (1)  ·  Adrenal Hyperplasia, Congenital (1)  ·  Adrenoleukodystrophy (1)  ·  Andersen Syndrome (1)  ·  Anemia, Diamond-Blackfan (1)  ·  Anemia, Sickle Cell (1)  ·  Argininosuccinic Aciduria (1)  ·  Aspartylglucosaminuria (1)  ·  Ataxia (1)  ·  Ataxia with vitamin E deficiency (1)  ·  Basal ganglia disease, biotin-responsive (1)

Broader conditions

Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Metabolic Diseases (2)  ·  Musculoskeletal Diseases (2)  ·  Nervous System Diseases (2)  ·  Neurobehavioral Manifestations (2)  ·  Neurologic Manifestations (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Abnormalities, Multiple (1)  ·  Adrenal Gland Diseases (1)  ·  Adrenal Insufficiency (1)  ·  Adrenogenital Syndrome (1)  ·  Albinism (1)

Interventions

Genetic Therapy (1)

Sponsors

National Taiwan University Hospital (3)  ·  Centre Hospitalier Universitaire de Liege (1)  ·  Istituto Giannina Gaslini (1)  ·  Krzysztof Bankiewicz (1)  ·  PTC Therapeutics (1)  ·  Shanghai Jiao Tong University School of Medicine (1)  ·  Shanghai Vitalgen BioPharma Co., Ltd. (1)  ·  University Hospital, Montpellier (1)  ·  University Medical Centre Ljubljana (1)

Countries

Taiwan (4)  ·  China (2)  ·  United States (2)  ·  Belgium (1)  ·  France (1)  ·  Israel (1)  ·  Italy (1)  ·  Slovenia (1)

Top investigators

Jiwen Wang, Doctor (1)  ·  Krystof Bankiewicz, MD, PhD (1)  ·  Laurent Servais (1)  ·  Wuh-Liang Hwu, M.D., Ph.D. (1)  ·  Yin-Hsiu Chien, MD.,PhD (1)

Results publications

PMID 34763085, PMID 30169182, PMID 34253733, PMID 42773379